Roles of mast cells in the pathogenesis of inflammatory myopathy

Arthritis Research and Therapy

Volumn 16, Issue 2, 2014, Pages

  Yokota, Masaya ^a   Suzuki, Kotaro ^a   Tokoyoda, Koji ^a   Meguro, Kazuyuki ^a   Hosokawa, Junichi ^a   Tanaka, Shigeru ^a   Ikeda, Kei ^a   Mikata, Takashi ^b   Nakayama, Toshinori ^a,c   Kohsaka, Hitoshi ^d   Nakajima, Hiroshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b SHIMOSHIZU HOSPITAL   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE HYDROGEN TETRAZOLIUM REDUCTASE; PROTEIN C; UNCLASSIFIED DRUG; CREATINE KINASE; EVANS BLUE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; TOLONIUM CHLORIDE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CD8+ T LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE PREDISPOSITION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MACROPHAGE; MALE; MAST CELL; MOUSE; MUSCLE BIOPSY; MYOSITIS; NONHUMAN; POLYMYOSITIS; PROTEIN C INDUCED MYOSITIS; SKELETAL MUSCLE; WILD TYPE; ANIMALS; HUMANS; IMMUNOLOGY; MAST CELLS; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; PATHOLOGY; ALLERGIC DISEASE; ANIMAL CELL; BECKER MUSCULAR DYSTROPHY; BONE MARROW DERIVED MAST CELL; CELL FUNCTION; CELL INFILTRATION; ENDOMYSIUM; ENGRAFTMENT; HISTOLOGY; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INTERSTITIAL LUNG DISEASE; LIMB GIRDLE MUSCULAR DYSTROPHY; MORBIDITY; MUSCULAR DYSTROPHY; PATHOGENESIS; PERIMYSIUM;

ANIMALS; HUMANS; MAST CELLS; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOSITIS;

EID: 84925011190     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4512     Document Type: Article

References (28)

1. Galli SJ, Nakase S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6:135-142. 10.1038/ni1158, 15662442.
2. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as " tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005, 23:749-786. 10.1146/annurev.immunol.21.120601.141025, 15771585.
3. Sayed BA, Christy A, Quirion MR, Brown MA. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008, 26:705-739. 10.1146/annurev.immunol.26.021607.090320, 18370925.
4. Lee DM, Friend DS, Gurish MF, Benoit C, Mathis D, Brenner MB. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 2002, 297:1689-1692. 10.1126/science.1073176, 12215644.
5. Secor VH, Secor WE, Gutekunst CA, Brown MA. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 2006, 191:813-821.
6. Geoffrey R, Jia S, Kwitek AE, Woodiff J, Ghosh S, Lernmark A, Wang X, Hessner MJ. Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the biobreeding rat. J Immunol 2006, 177:7275-7286.
7. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, Sharpe AH, Stevens RL. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999, 400:769-772. 10.1038/23481, 10466726.
8. Dalakas MC. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Pract Rheumatol 2006, 2:219-227. 10.1038/ncprheum0140, 16932688.
9. Mammen AL. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol 2011, 7:343-354. 10.1038/nrneurol.2011.63, 21654717.
10. Sugihara T, Sekine C, Nakae T, Kohyama K, Harigai M, Iwakura Y, Matsumoto Y, Miyasaka N, Kohsaka H. A new murine model to define the critical pathologic and therapeutic mediators of polymyositis. Arthritis Rheum 2007, 56:1304-1314. 10.1002/art.22521, 17394136.
11. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). New Engl J Med 1975, 292:344-347. 10.1056/NEJM197502132920706, 1090839.
12. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). New Engl J Med 1975, 292:403-407. 10.1056/NEJM197502202920807, 1089199.
13. Studynkova JT, Charvat F, Jarosova K, Vencovsky J. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology 2007, 46:1174-1179. 10.1093/rheumatology/kem088, 17500079.
14. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997, 407:313-319. 10.1016/S0014-5793(97)00313-X, 9175875.
15. Okiyama N, Sugihara T, Iwakura Y, Yokozeki H, Miyasaka Y, Kohsaka H. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A. Arthritis Rheum 2009, 60:2505-2512. 10.1002/art.24689, 19644888.
16. Sugihara T, Okiyama N, Suzuki M, Kohyama K, Matsumoto Y, Miyasaka N, Kohsaka H. Definitive engagement of cytotoxic CD8 T cells in C protein-induced myositis, a murine model of polymyositis. Arthritis Rheum 2010, 62:3088-3092. 10.1002/art.27625, 20583106.
17. Suzuki K, Verma IM. Phosphorylation of SNAP-23 by IκB Kinase 2 regulates mast cell degranulation. Cell 2008, 134:485-495. 10.1016/j.cell.2008.05.050, 2586340, 18692471.
18. Nicaise C, Mitrecic D, Demetter P, De Decker R, Authelet M, Boom A, Pochet R. Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. Brain Res 2009, 1301:152-162.
19. Abraham WM. Tryptase: potential role in airway inflammation and remodeling. Am J Physiol Lung Cell Mol Physiol 2002, 282:L193-L196.
20. Shrestha S, Wershil B, Sarwark JF, Niewold TB, Philipp T, Pachman LM. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum 2010, 62:2813-2822. 10.1002/art.27529, 3312790, 20506305.
21. Binstadt BA, Patel PR, Alencar H, Nigrovic PA, Lee DM, Mahmood U, Weissleder R, Mathis D, Benoit C. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol 2006, 7:284-292. 10.1038/ni1306, 16444258.
22. Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005, 57:664-678. 10.1002/ana.20464, 15852401.
23. Kalesnikoff J, Galli S. New developments in mast cell biology. Nat Immunol 2008, 9:1215-1223. 10.1038/ni.f.216, 2856637, 18936782.
24. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007, 217:304-328. 10.1111/j.1600-065X.2007.00520.x, 17498068.
25. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8:478-486. 10.1038/nri2327, 2855166, 18483499.
26. Reber LL, Marichal T, Galli SJ. New models for analyzing mast cell functions in vivo. Trends in Immunol 2012, 33:613-625.
27. Kohsaka H. Current insights in polymyositis and dermatomyositis. Clin Exp Neuroimmunol 2010, 1:22-32.
28. Gordon JR. Monocyte chemoattractant peptide-1 expression during cutaneous allergic reactions in mice is mast cell dependent and largely mediates the monocyte recruitment response. J Allergy Clin Immunol 2000, 106:110-116. 10.1067/mai.2000.107036, 10887313.